Related references
Note: Only part of the references are listed.Quantification of Pneumocystis jirovecii: Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes
Sarah Delliere et al.
JOURNAL OF FUNGI (2020)
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2019)
Serial Detection of Circulating Mucorales DNA in Invasive Mucormycosis: A Retrospective Multicenter Evaluation
Toine Mercier et al.
JOURNAL OF FUNGI (2019)
Evaluation of a Novel Mitochondrial Pan-Mucorales Marker for the Detection, Identification, Quantification, and Growth Stage Determination of Mucormycetes
Rita Caramalho et al.
JOURNAL OF FUNGI (2019)
Molecular Strategies to Diagnose Mucormycosis
Laurence Millon et al.
JOURNAL OF FUNGI (2019)
Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis
Anne-Pauline Bellanger et al.
BONE MARROW TRANSPLANTATION (2018)
Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016)
Jessie Bourcier et al.
MYCOSES (2017)
Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and Treatment
Matthieu Legrand et al.
CLINICAL INFECTIOUS DISEASES (2016)
Development and application of two independent real-time PCR assays to detect clinically relevant Mucorales species
Jan Springer et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Variation in copy number of the 28S rDNA of Aspergillus fumigatus measured by droplet digital PCR and analog quantitative real-time PCR
Alexandre Alanio et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2016)
Is It Time to Include CT “Reverse Halo Sign” and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?: Table 1.
Denis Caillot et al.
Open Forum Infectious Diseases (2016)
Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Aspergillus PCR: One Step Closer to Standardization
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Rapid identification of fungi by sequencing the ITSI and ITS2 regions using an automated capillary electrophoresis system
TM Pryce et al.
MEDICAL MYCOLOGY (2003)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
